Ratings ContextVision AB

Equities

CONTX

SE0014731154

Real-time Oslo Bors Other stock markets 03:47:47 2024-06-10 am EDT			5-day change	1st Jan Change
5.82 ^NOK	0.00%		-3.32%	-24.42%

May. 08	ContextVision AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
May. 08	Transcript : ContextVision AB, Q1 2024 Earnings Call, May 08, 2024

Summary

From a short-term investment perspective, the company presents a deteriorated fundamental situation
According to Refinitiv, the company's ESG score for its industry is poor.

Strengths

Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
Thanks to a sound financial situation, the firm has significant leeway for investment.

Weaknesses

According to forecast, a sluggish sales growth is expected for the next fiscal years.
The company's earnings growth outlook lacks momentum and is a weakness.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
Revenue estimates are regularly revised downwards for the current and coming years.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Advanced Medical Equipment & Technology

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
CONTEXTVISION AB	-24.42%	42.07M		C-
VEEVA SYSTEMS INC.	-4.87%	29.6B		C
PRO MEDICUS LIMITED	+31.35%	8.65B		C-
SECTRA AB	+36.80%	4.42B		B-
EVOLENT HEALTH, INC.	-28.91%	2.69B		C-
VERADIGM INC.	-9.91%	1.6B	-	C+
OMNICELL, INC.	-21.02%	1.36B		B
LUNIT INC.	-35.78%	1.1B		-
SIMULATIONS PLUS, INC.	+3.28%	924M		C
B-SOFT CO.,LTD.	-43.36%	791M		-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes